Nuo Therapeutics, Inc. (AURX)

Market Cap	58.08M +21.6%
Revenue (ttm)	3.31M +142.7%
Net Income	-2.51M
EPS	-0.05
Shares Out	48.40M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,509
Average Volume	5,455
Open	1.200
Previous Close	1.200
Day's Range	1.200 - 1.200
52-Week Range	0.936 - 3.230
Beta	-831.10
RSI	41.45
Earnings Date	May 7, 2026

About Nuo Therapeutics

Nuo Therapeutics, Inc. operates as a regenerative therapies company that develops, commercializes, and markets cell-based technologies that harness the regenerative capacity of the human body to trigger natural healing in the United States. The company offers the Aurix System, which separates autologous blood to produce a platelet-based therapy for the chronic wound care market. Its customers include hospital outpatient wound care clinics and other private practice physicians treating chronic wounds. The company was formerly known as Cytomedix,...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1998
• Employees: 10
• Stock Exchange: OTCMKTS
• Ticker Symbol: AURX

Financial Performance

In 2025, Nuo Therapeutics's revenue was $3.31 million, an increase of 142.72% compared to the previous year's $1.37 million. Losses were -$2.51 million, 8.11% more than in 2024.